nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Simvastatin—atherosclerosis	0.104	0.118	CbGbCtD
Pyrimethamine—CYP2C8—Lovastatin—atherosclerosis	0.102	0.116	CbGbCtD
Pyrimethamine—CYP2C8—Pravastatin—atherosclerosis	0.102	0.116	CbGbCtD
Pyrimethamine—CYP2D6—Niacin—atherosclerosis	0.0839	0.0953	CbGbCtD
Pyrimethamine—CYP2C9—Rosuvastatin—atherosclerosis	0.078	0.0887	CbGbCtD
Pyrimethamine—CYP2C9—Simvastatin—atherosclerosis	0.0725	0.0824	CbGbCtD
Pyrimethamine—CYP2C9—Lovastatin—atherosclerosis	0.071	0.0807	CbGbCtD
Pyrimethamine—CYP2C9—Pravastatin—atherosclerosis	0.071	0.0807	CbGbCtD
Pyrimethamine—CYP2D6—Simvastatin—atherosclerosis	0.0663	0.0754	CbGbCtD
Pyrimethamine—CYP2D6—Pravastatin—atherosclerosis	0.0649	0.0738	CbGbCtD
Pyrimethamine—CYP2D6—Lovastatin—atherosclerosis	0.0649	0.0738	CbGbCtD
Pyrimethamine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00245	0.0413	CcSEcCtD
Pyrimethamine—Haematuria—Rosuvastatin—atherosclerosis	0.00236	0.0398	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00229	0.0387	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00208	0.0351	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00207	0.0349	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00195	0.0328	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lovastatin—atherosclerosis	0.00178	0.03	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00176	0.0296	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00175	0.0294	CcSEcCtD
Pyrimethamine—Erythema multiforme—Simvastatin—atherosclerosis	0.00167	0.0281	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00155	0.0261	CcSEcCtD
Pyrimethamine—Erythema multiforme—Pravastatin—atherosclerosis	0.00151	0.0254	CcSEcCtD
Pyrimethamine—Leukopenia—Lovastatin—atherosclerosis	0.00147	0.0247	CcSEcCtD
Pyrimethamine—Leukopenia—Simvastatin—atherosclerosis	0.00137	0.0231	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00134	0.0226	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00131	0.0221	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00131	0.0221	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00129	0.0217	CcSEcCtD
Pyrimethamine—Anorexia—Lovastatin—atherosclerosis	0.00128	0.0215	CcSEcCtD
Pyrimethamine—Leukopenia—Niacin—atherosclerosis	0.00126	0.0212	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00125	0.0211	CcSEcCtD
Pyrimethamine—Leukopenia—Pravastatin—atherosclerosis	0.00124	0.0209	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00123	0.0207	CcSEcCtD
Pyrimethamine—Anorexia—Simvastatin—atherosclerosis	0.00119	0.0201	CcSEcCtD
Pyrimethamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00116	0.0196	CcSEcCtD
Pyrimethamine—Decreased appetite—Lovastatin—atherosclerosis	0.00116	0.0196	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Niacin—atherosclerosis	0.00115	0.0194	CcSEcCtD
Pyrimethamine—Decreased appetite—Ezetimibe—atherosclerosis	0.00114	0.0192	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00113	0.0191	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00111	0.0187	CcSEcCtD
Pyrimethamine—Anorexia—Niacin—atherosclerosis	0.0011	0.0185	CcSEcCtD
Pyrimethamine—Decreased appetite—Simvastatin—atherosclerosis	0.00109	0.0183	CcSEcCtD
Pyrimethamine—Anorexia—Pravastatin—atherosclerosis	0.00108	0.0182	CcSEcCtD
Pyrimethamine—Decreased appetite—Niacin—atherosclerosis	0.001	0.0168	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lovastatin—atherosclerosis	0.000986	0.0166	CcSEcCtD
Pyrimethamine—Decreased appetite—Pravastatin—atherosclerosis	0.000984	0.0166	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000967	0.0163	CcSEcCtD
Pyrimethamine—Hypersensitivity—Simvastatin—atherosclerosis	0.000923	0.0155	CcSEcCtD
Pyrimethamine—Vomiting—Lovastatin—atherosclerosis	0.000851	0.0143	CcSEcCtD
Pyrimethamine—Hypersensitivity—Niacin—atherosclerosis	0.000847	0.0143	CcSEcCtD
Pyrimethamine—Vomiting—Ezetimibe—atherosclerosis	0.000835	0.0141	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pravastatin—atherosclerosis	0.000834	0.0141	CcSEcCtD
Pyrimethamine—Vomiting—Simvastatin—atherosclerosis	0.000796	0.0134	CcSEcCtD
Pyrimethamine—Vomiting—Niacin—atherosclerosis	0.000731	0.0123	CcSEcCtD
Pyrimethamine—Vomiting—Pravastatin—atherosclerosis	0.00072	0.0121	CcSEcCtD
Pyrimethamine—DHFR—Metabolism—SCARB1—atherosclerosis	7.54e-05	0.00125	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	7.53e-05	0.00125	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	7.48e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	7.48e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	7.48e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	7.48e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	7.47e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	7.43e-05	0.00123	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	7.38e-05	0.00122	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	7.36e-05	0.00122	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	7.2e-05	0.00119	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	7.2e-05	0.00119	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	7.13e-05	0.00118	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—HMGCR—atherosclerosis	7.12e-05	0.00118	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	7.07e-05	0.00117	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	6.94e-05	0.00115	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	6.84e-05	0.00113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	6.58e-05	0.00109	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	6.5e-05	0.00108	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	6.42e-05	0.00106	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	6.36e-05	0.00105	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCA1—atherosclerosis	6.35e-05	0.00105	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOB—atherosclerosis	6.23e-05	0.00103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLTP—atherosclerosis	6.11e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	6.08e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	6.08e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	6.08e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	6.08e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	6.01e-05	0.000996	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—LPL—atherosclerosis	5.95e-05	0.000986	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.8e-05	0.000962	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PRKCG—atherosclerosis	5.78e-05	0.000958	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.67e-05	0.000939	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.63e-05	0.000933	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.6e-05	0.000927	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.57e-05	0.000922	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MAPK3—atherosclerosis	5.55e-05	0.00092	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.47e-05	0.000906	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—HMOX1—atherosclerosis	5.45e-05	0.000902	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.36e-05	0.000887	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTHFR—atherosclerosis	5.36e-05	0.000887	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	5.34e-05	0.000885	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG8—atherosclerosis	5.3e-05	0.000878	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LTA4H—atherosclerosis	5.3e-05	0.000878	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	5.29e-05	0.000877	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.23e-05	0.000867	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOB—atherosclerosis	5.22e-05	0.000864	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PDGFB—atherosclerosis	5.21e-05	0.000864	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.17e-05	0.000857	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—atherosclerosis	5.08e-05	0.000841	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLTP—atherosclerosis	5.02e-05	0.000832	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOE—atherosclerosis	4.99e-05	0.000826	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—LPL—atherosclerosis	4.98e-05	0.000825	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLTP—atherosclerosis	4.98e-05	0.000824	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MAPK3—atherosclerosis	4.96e-05	0.000822	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.94e-05	0.000819	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CAV1—atherosclerosis	4.94e-05	0.000819	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOA1—atherosclerosis	4.93e-05	0.000817	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPX1—atherosclerosis	4.86e-05	0.000805	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CD36—atherosclerosis	4.73e-05	0.000784	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS2—atherosclerosis	4.65e-05	0.00077	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.61e-05	0.000764	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.58e-05	0.000759	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.55e-05	0.000755	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MTHFR—atherosclerosis	4.49e-05	0.000743	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.45e-05	0.000737	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.41e-05	0.00073	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PPARA—atherosclerosis	4.4e-05	0.000729	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG8—atherosclerosis	4.35e-05	0.000721	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LTA4H—atherosclerosis	4.35e-05	0.000721	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LTA4H—atherosclerosis	4.32e-05	0.000715	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG8—atherosclerosis	4.32e-05	0.000715	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AGT—atherosclerosis	4.26e-05	0.000706	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.26e-05	0.000706	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—INS—atherosclerosis	4.26e-05	0.000706	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG1—atherosclerosis	4.19e-05	0.000694	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOE—atherosclerosis	4.18e-05	0.000692	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CAV1—atherosclerosis	4.14e-05	0.000685	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOA1—atherosclerosis	4.13e-05	0.000684	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.02e-05	0.000666	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FABP4—atherosclerosis	3.94e-05	0.000653	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LCAT—atherosclerosis	3.94e-05	0.000653	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SERPINE1—atherosclerosis	3.91e-05	0.000648	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA4—atherosclerosis	3.87e-05	0.000641	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP7A1—atherosclerosis	3.8e-05	0.000629	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CG—atherosclerosis	3.77e-05	0.000624	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS3—atherosclerosis	3.74e-05	0.000619	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PPARG—atherosclerosis	3.64e-05	0.000603	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.62e-05	0.0006	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.59e-05	0.000594	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—INS—atherosclerosis	3.57e-05	0.000591	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP27A1—atherosclerosis	3.51e-05	0.000582	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.46e-05	0.000573	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG1—atherosclerosis	3.44e-05	0.00057	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—atherosclerosis	3.42e-05	0.000566	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG1—atherosclerosis	3.41e-05	0.000565	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.37e-05	0.000559	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA2—atherosclerosis	3.33e-05	0.000552	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	3.33e-05	0.000552	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	3.33e-05	0.000552	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALOX15—atherosclerosis	3.33e-05	0.000552	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG5—atherosclerosis	3.29e-05	0.000545	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.29e-05	0.000544	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—atherosclerosis	3.27e-05	0.000542	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FABP4—atherosclerosis	3.23e-05	0.000536	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LCAT—atherosclerosis	3.23e-05	0.000536	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LCAT—atherosclerosis	3.21e-05	0.000531	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FABP4—atherosclerosis	3.21e-05	0.000531	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPA—atherosclerosis	3.18e-05	0.000526	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA4—atherosclerosis	3.18e-05	0.000526	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA4—atherosclerosis	3.15e-05	0.000521	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—atherosclerosis	3.13e-05	0.000518	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.12e-05	0.000517	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP7A1—atherosclerosis	3.09e-05	0.000512	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—BGN—atherosclerosis	3.08e-05	0.00051	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.05e-05	0.000506	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA5—atherosclerosis	3.05e-05	0.000504	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.96e-05	0.00049	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.95e-05	0.000488	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	2.93e-05	0.000486	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.9e-05	0.00048	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.88e-05	0.000478	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.87e-05	0.000476	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.86e-05	0.000475	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—atherosclerosis	2.86e-05	0.000474	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.86e-05	0.000474	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALOX5—atherosclerosis	2.83e-05	0.000469	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.81e-05	0.000466	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.75e-05	0.000455	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.73e-05	0.000453	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.73e-05	0.000453	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.73e-05	0.000453	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.73e-05	0.000453	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.71e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.71e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA2—atherosclerosis	2.71e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.71e-05	0.000449	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.7e-05	0.000447	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.68e-05	0.000443	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.67e-05	0.000443	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—atherosclerosis	2.67e-05	0.000441	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.62e-05	0.000433	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPA—atherosclerosis	2.61e-05	0.000432	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPA—atherosclerosis	2.59e-05	0.000428	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK3—atherosclerosis	2.55e-05	0.000422	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NAMPT—atherosclerosis	2.54e-05	0.000421	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—BGN—atherosclerosis	2.53e-05	0.000418	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.52e-05	0.000418	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LIPC—atherosclerosis	2.52e-05	0.000418	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOC3—atherosclerosis	2.51e-05	0.000415	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—BGN—atherosclerosis	2.5e-05	0.000415	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA5—atherosclerosis	2.5e-05	0.000414	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LDLR—atherosclerosis	2.49e-05	0.000413	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.49e-05	0.000412	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA5—atherosclerosis	2.48e-05	0.000411	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—atherosclerosis	2.47e-05	0.000409	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CETP—atherosclerosis	2.43e-05	0.000403	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.41e-05	0.000399	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.41e-05	0.000399	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.39e-05	0.000395	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.36e-05	0.000391	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.34e-05	0.000387	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.33e-05	0.000386	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SCARB1—atherosclerosis	2.33e-05	0.000386	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.32e-05	0.000385	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.3e-05	0.000382	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.27e-05	0.000376	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMGCR—atherosclerosis	2.2e-05	0.000365	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.13e-05	0.000353	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.08e-05	0.000345	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LIPC—atherosclerosis	2.07e-05	0.000343	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.07e-05	0.000342	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOC3—atherosclerosis	2.06e-05	0.000341	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.05e-05	0.00034	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LIPC—atherosclerosis	2.05e-05	0.00034	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDLR—atherosclerosis	2.05e-05	0.000339	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOC3—atherosclerosis	2.04e-05	0.000338	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDLR—atherosclerosis	2.03e-05	0.000336	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CETP—atherosclerosis	2e-05	0.000331	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.99e-05	0.000329	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CETP—atherosclerosis	1.98e-05	0.000328	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.96e-05	0.000325	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.91e-05	0.000317	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.9e-05	0.000314	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—atherosclerosis	1.86e-05	0.000308	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.85e-05	0.000306	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.81e-05	0.000299	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.79e-05	0.000297	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—atherosclerosis	1.72e-05	0.000284	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.68e-05	0.000279	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.62e-05	0.000268	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOB—atherosclerosis	1.61e-05	0.000267	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.61e-05	0.000267	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.6e-05	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.57e-05	0.00026	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPL—atherosclerosis	1.54e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—atherosclerosis	1.5e-05	0.000249	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CD36—atherosclerosis	1.46e-05	0.000242	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—atherosclerosis	1.44e-05	0.000238	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.00023	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.38e-05	0.000229	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.37e-05	0.000227	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARA—atherosclerosis	1.36e-05	0.000225	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOB—atherosclerosis	1.32e-05	0.000219	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AGT—atherosclerosis	1.32e-05	0.000218	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOB—atherosclerosis	1.31e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—atherosclerosis	1.29e-05	0.000214	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.29e-05	0.000213	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAV1—atherosclerosis	1.28e-05	0.000212	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.28e-05	0.000211	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000211	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPL—atherosclerosis	1.26e-05	0.000209	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPL—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.23e-05	0.000204	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—atherosclerosis	1.22e-05	0.000203	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CD36—atherosclerosis	1.2e-05	0.000199	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CD36—atherosclerosis	1.19e-05	0.000197	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.16e-05	0.000193	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.14e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.13e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARG—atherosclerosis	1.12e-05	0.000186	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARA—atherosclerosis	1.12e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARA—atherosclerosis	1.11e-05	0.000183	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—INS—atherosclerosis	1.1e-05	0.000183	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AGT—atherosclerosis	1.08e-05	0.000179	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AGT—atherosclerosis	1.07e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—atherosclerosis	1.06e-05	0.000176	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—atherosclerosis	1.05e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAV1—atherosclerosis	1.05e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA1—atherosclerosis	1.05e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAV1—atherosclerosis	1.04e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA1—atherosclerosis	1.04e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—atherosclerosis	1.01e-05	0.000167	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—atherosclerosis	9.67e-06	0.00016	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	9.56e-06	0.000158	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.48e-06	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARG—atherosclerosis	9.23e-06	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARG—atherosclerosis	9.15e-06	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—INS—atherosclerosis	9.05e-06	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—INS—atherosclerosis	8.97e-06	0.000149	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—atherosclerosis	8.84e-06	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—atherosclerosis	8.3e-06	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—atherosclerosis	8.23e-06	0.000136	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—atherosclerosis	7.94e-06	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—atherosclerosis	7.87e-06	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—atherosclerosis	7.26e-06	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—atherosclerosis	7.2e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—atherosclerosis	4.44e-06	7.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—atherosclerosis	3.65e-06	6.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—atherosclerosis	3.62e-06	5.99e-05	CbGpPWpGaD
